Health ❯ Healthcare ❯ Public Health

Infectious Diseases

COVID-19 Measles Influenza Flu HIV/AIDS Tuberculosis Covid-19 Norovirus Respiratory Infections Amoebic Meningoencephalitis Respiratory Syncytial Virus Antibiotic Resistance Respiratory Viruses Respiratory Syncytial Virus (RSV) Flu Season Whooping Cough Pneumonia Bacterial Infections Hepatitis B COVID-19 Variants Meningitis H5N1 Bird Flu Malaria Meningococcal Infections Antimicrobial Resistance Mpox Hepatitis C Chikungunya Avian Influenza Vibrio vulnificus Bronchiolitis Respiratory Illnesses Botulism Viral Infections Long COVID Flu Outbreak Measles Outbreak Flu and COVID-19 Vaccines Malaria Vaccines Scabies Listeriosis Hepatitis A RSV (Respiratory Syncytial Virus) Measles Outbreaks Sepsis Legionellosis Seasonal Illnesses Hepatitis C Virus Bird Flu Outbreak Bird Flu COVID-19 Outbreaks E. coli (EHEC) Hepatitis Triquinosis Legionnaires' Disease Rabies mRNA Vaccines Chikungunya Virus West Nile Virus RSV Awareness Mosquito-Borne Diseases Common Cold Covid-19 Vaccination Congenital Cytomegalovirus Cold Transmission Pediatric Health Vaccination Controversies Melioidosis Medical Assistance Human Metapneumovirus Strep A Outbreak Eye Infections Hospitalization Statistics Vaccine Development Preventive Measures Varicella (Chickenpox) Covid-19 Variants Epidemiology COVID-19 Vaccination Sexually Transmitted Infections Preventive Medicine Buruli Ulcer Staphylococcus aureus infections Humanitarian Crisis Outbreaks Diphtheria Flu (Influenza) Shigellosis Klebsiella Oxytoca Influenza Virus Legionella Outbreak Erythema Infectiosum Bacteraemia Quad-demic Hepatitis C and HIV Head Lice Hepatitis and HIV Elderly Care Chikungunya Fever Disease Outbreaks

Flu Surge Accelerates Nationwide as New York Sets Weekly Hospitalization Record

Driven by a drifted H3N2 subclade K variant, officials urge vaccination plus early antiviral use to reduce severe illness.

Drifted H3N2 Variant Drives Early U.S. Flu Rise as Hospitalizations Increase

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

Second Ichilov Doctor Tests Positive for Measles as Israel’s Outbreak Deepens

New Jersey Issues Measles Exposure Alert for Newark Airport Terminal B

JAMA Study Finds 2024–2025 COVID Vaccines Reduce Severe Illness, With Protection Waning by 20 Weeks

CDC Finalizes Shift to Case-by-Case COVID Vaccination and Separate Chickenpox Shot for Toddlers

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks

CDC Tallies 109 Pediatric Flu-Linked Encephalopathy Cases and 280 Deaths in 2024–25

Newborn Dried Blood Spot PCR Reliably Detects Congenital CMV, Study Finds

Swedish Study Finds Healthy Newborns at High Risk of Severe RSV, Spurring Expanded Protections

Measles Resurgence Triggers New Alerts in Australia as Alabama Confirms First Case Since 2002

Monthly Oral PrEP Candidate MK-8527 Shows Early Promise in Merck Study

Angela Bassett Sets Expectations for 9-1-1 Season 9 as Fans Press for Answers on Peter Krause

WHO Review Finds Hepatitis B Care Falling Short, Putting 2030 Goals at Risk

Israel Reports Second Toddler Death in Jerusalem-Area Measles Outbreak

Flesh-Eating Vibrio Infections Surge Along Gulf Coast

Guidelines Shift to Universal Hepatitis C Screening in Emergency Departments After Trial Shows 34% Boost in Case Detection

CDC Panel Recommends Merck’s Enflonsia Monoclonal Antibody for Babies

Cidara’s CD388 Antiviral Achieves Up to 76% Flu Protection in Phase 2b Trial